RNA Modification and Processing  4th Symposium on Nucleic Acid Modifications

##### **[RNA Modification and Processing 4th Symposium on Nucleic Acid Modifications](https://converia.uni-mainz.de/frontend/index.php?folder_id=987&page_id=), 23-25 September, 2024, IMB Mainz, Germany**


**Objective**

RNA is a key component in the development of all life forms and it is involved in all the mechanisms in which cells express genes. This conference focuses on how modifications and processing together determine RNA maturation, and in turn control RNA effector functions and their regulatory impact on gene expression.

The symposium will bring together internationally outstanding researchers to present topics at the forefront of:

-  Chemical and structural biology of nucleic acid modifications
-   Interactions and dynamics of nucleic acid modifications   
-   Detection and prediction of RNA modifications
-   Interplay between RNA modifications and RNA processing
-   Insights into the functions of RNA modifications

**_Scientific Organizers:_**

1. Mark Helm -Johannes Gutenberg-University, Mainz, DE
2. Julian König - Institute of Molecular Biology (IMB), Mainz, DE
3. Francesca Tuorto - Medical Faculty Mannheim of Heidelberg University, Mannheim, DE


[For more information, please visit WWW](https://converia.uni-mainz.de/frontend/index.php?folder_id=987&page_id=).



RNA Modification and Processing
4th Symposium on Nucleic Acid Modifications
23-25 September 2024
IMB Mainz, Germany

RNA Modification and Processing.gif

RNA Modification and Processing

 COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. (www.cost.eu) | The TRANSLACORE Cost Action is bridging disciplines and expertise across Europe in order to advance an emerging field in cancer biology: translational control in cancer. It is providing a unique opportunity to understand this biological process leading to reconsider our view of gene expression control in this disease and deliver novel therapeutic opportunities.

Search in the Translacore

RNA Modification and Processing